J Gimbel, MD
Clinical Cardiac Electrophysiology · Fort Wayne, INNPI 1932199627
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (30.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 47.1% of the total. Reporting peaked in 2019 at $10,194 and has fallen 86.0% since, to $1,431 in 2025.
Across 219 payments — averaging $114.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$12K
- Medtronic$6K
- Abbott$4K
- Boston Scientific$927
- Biosense Webster, Inc.$643
- Johnson & Johnson$453
- plus $1K from 16 others
What the payments were for
- Consulting fees$2,97512%
- Speaking & faculty fees$7,20029%
- Travel & lodging$7,30629%
- Food & beverage$7,59930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 35 | $11,801 |
| Medtronic(2 entities) | 41 | $5,788 |
| Abbott | 53 | $4,235 |
| Boston Scientific | 20 | $927 |
| Biosense Webster, Inc. | 8 | $643 |
| Johnson & Johnson | 17 | $453 |
| Pfizer | 6 | $201 |
| Novartis | 7 | $182 |
| Cardiofocus, Inc. | 4 | $174 |
| AstraZeneca | 2 | $139 |
| Biotronik Inc. | 4 | $99 |
| E.r. Squibb & Sons, L.L.C. | 5 | $80 |
| Cardiva Medical, Inc. | 3 | $64 |
| Sanofi-aventis U.S. LLC | 3 | $62 |
| Kestra Medical Technology Services, Inc. | 1 | $41 |
| Impulse Dynamics (USA) Inc. | 1 | $36 |
| Lexicon Pharmaceuticals, Inc. | 2 | $33 |
| Boehringer Ingelheim | 2 | $32 |
| Vital Connect, Inc | 1 | $28 |
| Cvrx, Inc. | 2 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Altathera Pharmaceuticals LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$11,325
- Arctic Front$1,610
- ENSITE PRECISION$1,404
- AGILIS$806
- Micra$358
- JOT DX$306
- Carto 3$263
- EMBLEM$142
- NA$136
- FARXIGA$124
- QDOT MICRO Catheter$122
- ENSITE$116
- HeartLight System$112
- HeartMate 3 Left Ventricular Assist Device$110
- AMPLIA MRI QUAD CRT-D SURESCAN$105
How this compares
$25,080 in reported general payments places this provider in the 60th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 355 | $407,468 |
| XareltoRivaroxaban | 139 | $147,989 |
| JardianceEmpagliflozin | 35 | $48,383 |
| EntrestoSacubitril/Valsartan | 29 | $44,472 |
| FarxigaDapagliflozin Propanediol | 12 | $8,555 |
| Flecainide Acetate | 69 | $3,425 |
| Colchicine | 54 | $3,114 |
| Mexiletine Hcl | 26 | $2,901 |
| Dofetilide | 39 | $2,870 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 64 | $2,826 |
| Metoprolol Succinate | 187 | $2,209 |
| SotalolSotalol Hcl | 30 | $895 |
| Amiodarone Hcl | 42 | $680 |
| Carvedilol | 74 | $586 |
| Spironolactone | 83 | $496 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $201 | $407,468355 claims |
| Johnson & JohnsonXarelto | $453 | $147,989139 claims |
| Boehringer IngelheimJardiance | $32 | $48,38335 claims |
| NovartisEntresto | $182 | $44,47229 claims |
| AstraZenecaFarxiga | $139 | $8,55512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Fort Wayne
- Jason RodriguezFort Wayne$33K
- Christopher EvensonFort Wayne$29K
- David SchleinkoferFort Wayne$19K
- Jonathan ShiraziFort Wayne$8K
- Brian CooperFort Wayne$6K
- Eric PrystowskyIndianapolis$1.1M
- Chad BonhommeWestfield$925K
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.